| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |